Journal Name: International Journal of Biopharmaceutical Sciences
ISSN: 2517-7338
DOI: 10.31021
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
James Michael Hardin
Provost and Vice President,United States
Alok Bhushan
Professor,United States
Andrew Allen Webster
Professor,United States
Yuri L. Lyubchenko
Professor,United States
Narasimha Murthy S
Professor,United States
Francisco Lopez-Munoz
Professor,Spain
Aruni Wilson
Associate Professor,United States
H Fai Poon
R&D Scientist,United States
Suleyman Aydin
Professor,Turkey
Hayriye Eda ?atana Kara
Associate Professor,Turkey
Bayoumi Hamuda H
Professor,Hungary
Antonio Simone Laganà
Professor,Italy
Monzurul A. Roni
Assistant Professor,United States
Verissimo M T
Assistant Professor,Portugal
Chang-Sik Ha
Professor,Korea, Republic of
Mohamed Eddouks
Professor,Morocco
Massoud Kaykhaii
Professor,Iran (Islamic Republic of)
Giovanni Vitale S
Professor of Unit of Gynaecology and Obstetrics,Italy
Haseeb Ahmad Khan
Professor,United Arab Emirates
Hussein Osman Ammar
Professor,Egypt
Viroj Wiwanitkit
Professor,Thailand
Simone Brogi
Research Associate,Italy
Ali Demir Sezer, Ph.D.
Associate Professor,Turkey
Mohamed Abdel Daim
Associate Professor,Egypt
Weien Yuan
Associate Professor,China
Islam M. Ghazi
Assitant Professor,United States
Christian Agyare
Professor,Ghana
Gian Maria Pacifici
Associate Professor,Italy
Nicola Micale
Researcher,Italy
Thiagarajan Venkatesan
Associate Research Scientist,United States
The International Journal of Biopharmaceutical Sciences (IJBPS) is an international, peer-reviewed, open access journal published by Boffin Access Limited. The journal is dedicated to advancing research and innovation in the field of biopharmaceutical sciences, bringing together cutting-edge studies on drug discovery, development, delivery, and therapeutic applications.
IJBPS provides a trusted platform for scientists, academicians, clinicians, and industry experts to disseminate novel findings that shape the future of pharmaceuticals, biotechnology, and translational medicine.
The journal welcomes high-quality submissions across the broad spectrum of biopharmaceutical sciences, including but not limited to:
Drug discovery, design, and development
Biopharmaceutical formulation and manufacturing
Pharmacokinetics, pharmacodynamics, and drug metabolism
Nanomedicine and targeted drug delivery systems
Protein, peptide, and nucleic acid therapeutics
Biosimilars and biologics development
Biopharmaceutical regulations, quality control, and GMP compliance
Immunopharmaceuticals and vaccine technology
Gene therapy and cell-based therapeutics
Biopharmaceutics in oncology, neurology, cardiology, and infectious diseases
Clinical trials and translational research in biopharma
Emerging technologies in personalized and precision medicine
IJBPS fosters a multidisciplinary dialogue that bridges basic science, applied research, and clinical application.
Global Readership – Open access ensures maximum visibility and impact across academia, healthcare, and industry.
Rigorous Peer Review – Submissions undergo double-blind peer review to maintain the highest scientific and ethical standards.
Rapid and Reliable Publication – Accepted articles are published promptly, accelerating knowledge dissemination.
Cross-Disciplinary Impact – Encourages collaboration between pharmaceutical scientists, clinicians, engineers, and policy experts.
Author Rights – Authors retain copyright under Creative Commons licensing, enabling unrestricted sharing and citation.
Multiple Formats – Articles published in PDF, HTML, and enriched formats (supplementary data, tables, figures).
Innovation Focus – Special issues on cutting-edge topics such as nanomedicine, biosimilars, and regenerative therapies.
The International Journal of Biopharmaceutical Sciences follows globally recognized guidelines including COPE and ICMJE. Editorial independence, objectivity, and scientific merit are the core principles guiding all publication decisions.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.